Lifecore Biomedical (LFCR) Institutional Ownership $7.59 -0.01 (-0.13%) Closing price 04:00 PM EasternExtended Trading$7.59 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lifecore Biomedical (NASDAQ:LFCR)CurrentInstitutional OwnershipPercentage83.36%Number ofInstitutional Buyers(last 12 months)47TotalInstitutional Inflows(last 12 months)$51.31MNumber ofInstitutional Sellers(last 12 months)18TotalInstitutional Outflows(last 12 months)$18.71M Get LFCR Insider Trade Alerts Want to know when executives and insiders are buying or selling Lifecore Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LFCR Institutional Buying and Selling by Quarter Lifecore Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 State of Wyoming8,504$69K0.0%N/A0.023% 8/18/2025 Tactive Advisors LLC15,495$126K0.0%N/A0.041% 8/15/2025 Grizzlyrock Capital LLC734,533$5.96M4.1%N/A1.963% 8/15/2025 Bank of America Corp DE20,545$167K0.0%-24.6%0.055% 8/14/2025 The Manufacturers Life Insurance Company 10,854$88K0.0%N/A0.029% 8/14/2025 Qube Research & Technologies Ltd17,666$143K0.0%-68.1%0.047% 8/14/2025 22NW LP264,180$2.15M1.5%-84.9%0.706% 8/14/2025 Pale Fire Capital SE30,686$249K0.0%N/A0.082% 8/13/2025 Diametric Capital LP33,472$272K0.1%N/A0.089% 8/13/2025 Marshall Wace LLP35,352$287K0.0%-47.9%0.094% Get the Latest News and Ratings for LFCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. 8/13/2025 Greenhaven Road Investment Management L.P.3,694,832$30.00M10.3%+2.2%9.877% 8/13/2025 Invesco Ltd.379,413$3.08M0.0%N/A1.014% 8/12/2025 Steward Partners Investment Advisory LLC32,761$266K0.0%+8.4%0.088% 8/12/2025 DCF Advisers LLC462,987$3.76M1.7%-4.1%1.238% 8/12/2025 Rhumbline Advisers38,091$309K0.0%+54.0%0.102% 8/11/2025 ARS Investment Partners LLC25,000$203K0.0%+150.0%0.068% 8/11/2025 Wittenberg Investment Management Inc.17,223$140K0.1%+40.9%0.047% 8/8/2025 Intech Investment Management LLC17,263$140K0.0%+62.8%0.047% 8/8/2025 Geode Capital Management LLC775,493$6.30M0.0%+3.3%2.095% 8/8/2025 Quinn Opportunity Partners LLC202,252$1.64M0.1%+31.8%0.546% 8/1/2025 GWN Securities Inc.13,088$106K0.0%N/A0.035% 6/27/2025 Goldman Sachs Group Inc.87,998$620K0.0%+16.8%0.238% 5/29/2025 Rhumbline Advisers24,730$174K0.0%-55.6%0.067% 5/16/2025 Goldman Sachs Group Inc.87,998$620K0.0%+16.8%0.238% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,785$104K0.0%+14.6%0.040% 5/14/2025 Gamco Investors INC. ET AL84,500$595K0.0%-1.7%0.228% 5/14/2025 Alpha Wave Global LP72,260$509K0.2%-38.0%0.195% 5/14/2025 MetLife Investment Management LLC10,787$76K0.0%-25.7%0.029% 5/13/2025 Summit Securities Group LLC3,690$26K0.0%N/A0.010% 5/13/2025 Boston Partners34,175$241K0.0%N/A0.092% 5/13/2025 Lepercq De Neuflize Asset Management LLC19,700$139K0.1%-13.2%0.053% 5/12/2025 Nuveen LLC28,837$203K0.0%N/A0.078% 5/9/2025 Charles Schwab Investment Management Inc.79,495$560K0.0%+6.8%0.215% 5/9/2025 DCF Advisers LLC483,000$3.40M1.6%-10.6%1.305% 5/8/2025 XTX Topco Ltd20,599$145K0.0%N/A0.056% 5/7/2025 Hurley Capital LLC5,000$35K0.0%N/A0.014% 4/29/2025 Bank of New York Mellon Corp83,663$589K0.0%+3.8%0.226% 4/8/2025 Rhumbline Advisers24,730$174K0.0%-55.6%0.067% 4/7/2025 GAMMA Investing LLC3,569$25K0.0%+1,839.7%0.010% 4/1/2025 MassMutual Private Wealth & Trust FSB4,687$33K0.0%-83.3%0.013% Backed by 140+ major investors, this small-cap just made a bold move. Full story inside. (Ad)In today’s market, small-cap companies with bold strategies can sometimes offer the most interesting growth stories. One NASDAQ-listed firm just announced a $500 million private placement that could expand to $1.25 billion — a move designed to rapidly scale its presence in a fast-emerging sector. What makes this story stand out isn’t just the size of the raise, but the caliber of support. Backed by more than 140 institutional investors and guided by industry veterans with experience at well-known firms, the company is positioning itself for an ambitious expansion strategy.For investors looking at innovative public companies with strong institutional backing, this could b2/17/2025 Squarepoint Ops LLC10,073$75K0.0%-63.7%0.027% 2/17/2025 Legion Partners Asset Management LLC4,431,823$32.93M22.0%+49.3%11.968% 2/17/2025 Deutsche Bank AG25,433$189K0.0%-91.9%0.069% 2/17/2025 Bridgeway Capital Management LLC78,800$585K0.0%+2.5%0.213% 2/17/2025 Bank of America Corp DE33,507$249K0.0%+25.3%0.090% 2/17/2025 BNP Paribas Financial Markets14,966$111K0.0%-72.5%0.040% 2/17/2025 325 Capital LLC2,162,466$16.07M6.2%+57.9%5.840% 2/14/2025 Northern Trust Corp221,498$1.65M0.0%+14.5%0.598% 2/14/2025 Boothbay Fund Management LLC87,142$647K0.0%-53.4%0.235% 2/14/2025 MetLife Investment Management LLC14,513$108K0.0%N/A0.039% 2/14/2025 Greenhaven Road Investment Management L.P.3,616,146$26.87M4.3%+62.2%9.765% 2/14/2025 Alpha Wave Global LP116,538$866K0.4%N/A0.315% 2/13/2025 Marshall Wace LLP133,191$990K0.0%-33.6%0.360% 2/13/2025 Gabelli Funds LLC13,500$100K0.0%-25.0%0.036% 2/13/2025 Barclays PLC33,972$253K0.0%+13.5%0.092% 2/13/2025 Invesco Ltd.555,607$4.13M0.0%N/A1.500% 2/13/2025 Wells Fargo & Company MN13,381$99K0.0%+29.0%0.036% 2/13/2025 Wittenberg Investment Management Inc.11,223$83K0.0%-80.6%0.030% 2/12/2025 Rangeley Capital LLC43,700$325K0.3%N/A0.118% 2/12/2025 Geode Capital Management LLC685,746$5.10M0.0%+14.7%1.852% 2/12/2025 Diametric Capital LP43,146$321K0.2%-42.9%0.117% 2/11/2025 Prudential Financial Inc.12,735$95K0.0%N/A0.034% 2/11/2025 DCF Advisers LLC539,989$4.01M1.9%+87.2%1.458% 2/7/2025Lepercq Multi Asset Fund22,700$169K0.1%N/A0.061% 2/6/2025 Charles Schwab Investment Management Inc.74,427$553K0.0%+23.0%0.201% 2/6/2025 Steward Partners Investment Advisory LLC27,184$202K0.0%+61.2%0.073% 2/4/2025 Bank of New York Mellon Corp80,572$599K0.0%+71.9%0.218% 1/30/2025 Rhumbline Advisers55,723$414K0.0%+125.9%0.150% 1/16/2025 ARS Investment Partners LLC10,000$74K0.0%N/A0.027% 1/16/2025 MassMutual Private Wealth & Trust FSB28,100$209K0.0%N/A0.076% 12/5/2024 272 Capital LP143,480$707K0.4%+511.1%0.390% 11/19/2024 Barclays PLC29,944$147K0.0%+301.7%0.081% 11/16/2024 Geode Capital Management LLC597,685$2.95M0.0%+10.3%1.623% 11/15/2024 Barclays PLC29,944$147K0.0%+301.7%0.081% 11/15/2024 Public Employees Retirement System of Ohio24,153$119K0.0%N/A0.066% 11/15/2024 Jane Street Group LLC36,246$179K0.0%+101.7%0.098% 11/15/2024 State Street Corp334,360$1.65M0.0%+10.2%0.908% 11/15/2024 Jacobs Levy Equity Management Inc.42,074$207K0.0%N/A0.114% 11/14/2024 272 Capital LP43,476$214K0.2%+85.2%0.118% 11/13/2024 BNP Paribas Financial Markets54,399$268K0.0%+2,640.5%0.148% 11/13/2024 Wittenberg Investment Management Inc.57,896$285K0.1%+287.8%0.157% 10/11/2024 Creative Planning14,000$69K0.0%N/A0.046% 8/15/2024 Legion Partners Asset Management LLC2,968,409$15.23M4.7%+0.6%9.790% 8/14/2024 272 Capital LP23,478$120K0.1%-83.9%0.077% 8/14/2024 Marshall Wace LLP300,120$1.54M0.0%+87.3%0.990% 8/13/2024 DCF Advisers LLC290,684$1.49M0.8%+2.1%0.959% 8/9/2024 Renaissance Technologies LLC11,000$56K0.0%N/A0.036% 8/8/2024 American Century Companies Inc.31,982$164K0.0%-46.2%0.105% 8/2/2024 Allegheny Financial Group LTD10,085$52K0.0%N/A0.033% 8/1/2024 Rhumbline Advisers26,899$138K0.0%+1,668.5%0.088% Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma7/26/2024 Bank of New York Mellon Corp63,776$327K0.0%N/A0.210% 5/28/2024 Boston Partners19,674$104K0.0%N/A0.065% 5/10/2024 Vanguard Group Inc.1,184,856$6.29M0.0%-12.3%3.908% 5/10/2024 Tocqueville Asset Management L.P.351,700$1.87M0.0%-12.4%1.160% 5/9/2024 State Board of Administration of Florida Retirement System21,544$114K0.0%N/A0.071% 5/7/2024 Cove Street Capital LLC1,283,780$6.82M2.2%+41.0%4.234% 5/7/2024 Oppenheimer Asset Management Inc.43,001$228K0.0%+79.9%0.142% 5/7/2024 SG Americas Securities LLC10,659$57K0.0%N/A0.035% 5/1/2024 Mirae Asset Global Investments Co. Ltd.10,860$58K0.0%N/A0.036% 4/30/2024 Cutter & CO Brokerage Inc.10,767$57K0.0%-30.8%0.036% (Data available from 1/1/2016 forward) LFCR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LFCR shares? During the previous two years, 74 institutional investors and hedge funds held shares of Lifecore Biomedical. The most heavily invested institutionals were Legion Partners Asset Management LLC ($32.93M), Greenhaven Road Investment Management L.P. ($30.00M), 325 Capital LLC ($16.07M), Cove Street Capital LLC ($6.82M), Geode Capital Management LLC ($6.30M), Vanguard Group Inc. ($6.29M), and Grizzlyrock Capital LLC ($5.96M).Learn more on Lifecore Biomedical's institutional investors. What percentage of Lifecore Biomedical's stock is owned by institutional investors? 83.36% of Lifecore Biomedical's stock is owned by institutional investors. Learn more on LFCR's institutional investor holdings. Which institutional investors have been buying Lifecore Biomedical's stock? Of the 59 institutional investors that purchased Lifecore Biomedical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Greenhaven Road Investment Management L.P. ($1.93M), Legion Partners Asset Management LLC ($1.48M), Invesco Ltd. ($935.02K), 325 Capital LLC ($792.68K), Grizzlyrock Capital LLC ($734.53K), DCF Advisers LLC ($396.44K), and Cove Street Capital LLC ($373.52K). How much institutional buying is happening at Lifecore Biomedical? Institutional investors have bought a total of 6,937,233 shares in the last 24 months. This purchase volume represents approximately $51.31M in transactions. Which of Lifecore Biomedical's major shareholders have been selling company stock? Of the 18 institutional investors that sold Lifecore Biomedical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: 22NW LP ($1.49M), Deutsche Bank AG ($290.29K), Boothbay Fund Management LLC ($100.00K), Marshall Wace LLP ($99.98K), DCF Advisers LLC ($77.00K), Rhumbline Advisers ($61.99K), and Wittenberg Investment Management Inc. ($46.67K). How much institutional selling is happening at Lifecore Biomedical? Institutional investors have sold a total of 2,381,297 shares in the last 24 months. This volume of shares sold represents approximately $18.71M in transactions. Related Companies LENZ Therapeutics Institutional Ownership Spyre Therapeutics Institutional Ownership Upstream Bio Institutional Ownership Mineralys Therapeutics Institutional Ownership Stoke Therapeutics Institutional Ownership Verve Therapeutics Institutional Ownership Praxis Precision Medicines Institutional Ownership Valneva Institutional Ownership CorMedix Institutional Ownership Nuvation Bio Institutional Ownership This page (NASDAQ:LFCR) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access